Similar articles

• Triple therapy for hepatitis C virus infection in patients receiving hemodialysis.

  Liu CH, Kao JH. Liu CH, et al. Ann Intern Med. 2014 Apr 15;160(8):581-2. doi: 10.7326/L14-5008-4. Ann Intern Med. 2014. PMID: 24733208 No abstract available.
• Hepatitis C treatment in dialysis patients: is a new dawn approaching?

  Gordon CE, Francis J. Gordon CE, et al. Am J Kidney Dis. 2014 Aug;64(2):178-80. doi: 10.1053/j.ajkd.2014.04.005. Epub 2014 May 3. Am J Kidney Dis. 2014. PMID: 24797524 No abstract available.
• Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

  Liu CH, Huang CF, Liu CJ, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Chen SI, Lin JW, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH. Liu CH, et al. Ann Intern Med. 2013 Dec 3;159(11):729-38. doi: 10.7326/0003-4819-159-11-201312030-00005. Ann Intern Med. 2013. PMID: 24297189 Clinical Trial.
• [Treatment of chronic hepatitis C virus infection in hemodialysis patients].

  Kaya S. Kaya S. Mikrobiyol Bul. 2008 Jul;42(3):525-34. Mikrobiyol Bul. 2008. PMID: 18822900 Review. Turkish.
• Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.

  Fabrizi F, Dixit V, Martin P, Messa P. Fabrizi F, et al. J Viral Hepat. 2011 Jul;18(7):e263-9. doi: 10.1111/j.1365-2893.2010.01405.x. Epub 2010 Nov 25. J Viral Hepat. 2011. PMID: 21108701